![]() |
Volumn 19, Issue 4, 2005, Pages 317-319
|
How many antihypertensives do patients need to achieve a target blood pressure? [1]
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ANTIHYPERTENSIVE AGENT;
ATENOLOL;
BENDROFLUMETHIAZIDE;
BLOOD PRESSURE MEASUREMENT;
CARDIOVASCULAR DISEASE;
CARDIOVASCULAR RISK;
CLINICAL TRIAL;
COHORT ANALYSIS;
DRUG DOSE REGIMEN;
DRUG EFFICACY;
GROUPS BY AGE;
HEALTH CARE COST;
HEALTH SURVEY;
HUMAN;
HYPERTENSION;
LETTER;
META ANALYSIS;
PHYSICIAN;
PRACTICE GUIDELINE;
PREVALENCE;
RISK BENEFIT ANALYSIS;
SEX DIFFERENCE;
SIDE EFFECT;
SYSTOLIC BLOOD PRESSURE;
TREATMENT OUTCOME;
UNITED KINGDOM;
ADULT;
AGED;
ANTIHYPERTENSIVE AGENTS;
BLOOD PRESSURE;
DOSE-RESPONSE RELATIONSHIP, DRUG;
DRUG ADMINISTRATION SCHEDULE;
FEMALE;
GREAT BRITAIN;
HUMANS;
HYPERTENSION;
MALE;
MIDDLE AGED;
PRACTICE GUIDELINES;
RETROSPECTIVE STUDIES;
|
EID: 17144385783
PISSN: 09509240
EISSN: None
Source Type: Journal
DOI: 10.1038/sj.jhh.1001823 Document Type: Letter |
Times cited : (7)
|
References (4)
|